Skip to main content
Top

Hepatology International

Issue 2/2015

Content (22 Articles)

Editorial

Autoimmune liver disease in Asian children

Giorgina Mieli-Vergani, Diego Vergani

Review Article

Sofosbuvir for treatment of chronic hepatitis C

Sarah Kattakuzhy, Rachel Levy, Shyam Kottilil

Review Article

Recent advances in hemochromatosis: a 2015 update

Dilum Ekanayake, Clinton Roddick, Lawrie W. Powell

Review Article

New cellular and molecular targets for the treatment of portal hypertension

Jordi Gracia-Sancho, Raquel Maeso-Díaz, Anabel Fernández-Iglesias, María Navarro-Zornoza, Jaime Bosch

Review Article

Management of post transplant hepatitis C in the direct antiviral agents era

Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel

Original Article

Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients

Charlie Laohapand, Emvalee Arromdee, Tawesak Tanwandee

Open Access Original Article

High rate of core promoter and precore mutations in patients with chronic hepatitis B

Sumbella F. Baqai, James Proudfoot, Debbie H. Yi, Michael Mangahas, Robert G. Gish

Original Article

Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy

Edith Y. Ho, Thomas Yau, Franck Rousseau, E. Jenny Heathcote, George K. K. Lau

Original Article

Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection

Ching-Sheng Hsu, Wei-Liang Liu, You-Chen Chao, Hans Hsienhong Lin, Tai-Chung Tseng, Chia-Chi Wang, Ding-Shinn Chen, Jia-Horng Kao

Open Access Original Article

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

Maria Buti, Scott Fung, Edward Gane, Nezam H. Afdhal, Robert Flisiak, Selim Gurel, John F. Flaherty, Eduardo B. Martins, Leland J. Yee, Phillip Dinh, Jeffrey D. Bornstein, G. Mani Subramanian, Harry L. A. Janssen, Jacob George, Patrick Marcellin

Original Article

Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians

Susanne Knapp, Zainab Zakaria, Mohamed Hashem, Hassan Zaghla, Salim I. Khakoo, Imam Waked, Mark Thursz, Sayed F. Abdelwahab

Open Access Original Article

New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan

Yusuke Kawamura, Kenji Ikeda, Yasuji Arase, Yushi Sorin, Taito Fukushima, Hideo Kunimoto, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada

Open Access Original Article

Association between retinal artery lesions and nonalcoholic fatty liver disease

Wen Yang, Hongtao Xu, Xiaohong Yu, Yuzhu Wang

Original Article

Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center

Swastik Agrawal, Ajay Duseja, Ashutosh Aggarwal, Ashim Das, Manu Mehta, Radha K. Dhiman, Yogesh Chawla

Original Article

Characteristics and outcome of autoimmune liver disease in Asian children

Way S. Lee, Su H. Lum, Chooi B. Lim, Sze Y. Chong, Kim M. Khoh, Ruey T. Ng, Kai M. Teo, Christopher C. M. Boey, Jayalakshmi Pailoor

Original Article

Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits

Ying Ding, Sheng-Xiang Rao, Caizhong Chen, Renchen Li, Meng-Su Zeng

Original Article

Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway

Xinjin Chi, Rui Zhang, Ning Shen, Yi Jin, Ayep Alina, Simin Yang, Shiqing Lin

Open Access Original Article

Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study

Tsunenobu Sato, Fukuo Kondo, Masaaki Ebara, Nobuyuki Sugiura, Shinichiro Okabe, Masahiko Sunaga, Masaharu Yoshikawa, Eiichiro Suzuki, Sadayuki Ogasawara, Yusuke Shinozaki, Yoshihiko Ooka, Tetsuhiro Chiba, Fumihiko Kanai, Takashi Kishimoto, Yukio Nakatani, Toshio Fukusato, Osamu Yokosuka

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.